Citadel Advisors’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Citadel Advisors’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,492	Closed	-$5.6K	–	15717
2025 Q1	$5.6K	Sell	1,492 -4,760	-76%	-$46.2K	﹤0.01%	13808
2024 Q4	$54.1K	Buy	+6,252	New	+$59.4K	﹤0.01%	12306
2024 Q1	–	Sell	-500	Closed	-$55.7K	–	15601
2023 Q4	$55.7K	Sell	500 -96	-16%	-$8.21K	﹤0.01%	11671
2023 Q3	$64.3K	Buy	+596	New	+$89.8K	﹤0.01%	11440

Other funds holding XAGE

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $915M AUM 19.16% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Citadel Advisors's XAGE Position: Q2 2025 in Review

Citadel Advisors sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2025, closing a stake of 1,492 shares — an estimated $5.6K sold.

Citadel Advisors first reported a position in XAGE in Q3 2023 and held it in 4 quarters. The position peaked at $64.3K in Q3 2023. 11 funds tracked by Wall St. Rank hold XAGE as of Q2 2025.

Citadel Advisors reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Citadel Advisors sold 1,492 Longevity Health Holdings, Inc. Common Stock shares in Q2 2025, an estimated $5.6K.
Citadel Advisors first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
Citadel Advisors's Longevity Health Holdings, Inc. Common Stock position peaked at $64.3K in Q3 2023.
11 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.